<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Microbiology of Lyme disease
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Microbiology of Lyme disease
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Microbiology of Lyme disease
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alan G Barbour, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Allen C Steere, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Keri K Hall, MD, MS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 07, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1776078715">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lyme disease is the most common tick-borne disease in the United States, Canada, and Europe [
         <a href="#rid1">
          1-3
         </a>
         ]. It is a bacterial infection caused by six species in the spirochete family
         <em>
          Borreliaceae
         </em>
         [
         <a href="#rid4">
          4
         </a>
         ]. The taxonomy of these spirochetes has been revised [
         <a href="#rid5">
          5
         </a>
         ], and the genus name is represented in the literature as either
         <em>
          Borrelia
         </em>
         or
         <em>
          Borreliella
         </em>
         . In either case, the abbreviation for the genus is "B" and stands for both terminologies in the discussion below.
        </p>
        <p>
         In
         <em>
         </em>
         North America, infection
         <em>
         </em>
         is caused primarily by
         <em>
          B. burgdorferi
         </em>
         and, less commonly, by
         <em>
          B. mayonii
         </em>
         .
         <em>
         </em>
         In Europe and Asia
         <em>
          ,
         </em>
         infection is caused primarily by either
         <em>
          B. afzelii
         </em>
         or
         <em>
          B. garinii
         </em>
         , less commonly by
         <em>
          B. burgdorferi
         </em>
         , and uncommonly by
         <em>
          B. spielmanii
         </em>
         or
         <em>
          B. bavariensis
         </em>
         .
        </p>
        <p>
         In nature, the reservoirs for these organisms are small mammals and birds, not deer. Humans acquire the infection from the bite of an infected tick of the genus
         <em>
          Ixodes
         </em>
         . The infection begins in the skin at the site of the tick bite. From there, the spirochetes may disseminate in the blood to other tissues and organs. The usual manifestations of Lyme disease involve the skin, joints, heart, and nervous system.
        </p>
        <p>
         The microbiology of Lyme disease will be reviewed here. Topics related to immunopathogenesis, epidemiology, prevention, clinical manifestations, diagnosis, and therapy of Lyme disease are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7901.html" rel="external">
          "Epidemiology of Lyme disease"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/14008.html" rel="external">
          "Immunopathogenesis of Lyme disease"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7895.html" rel="external">
          "Prevention of Lyme disease"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7916.html" rel="external">
          "Evaluation of a tick bite for possible Lyme disease"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7913.html" rel="external">
          "Clinical manifestations of Lyme disease in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6038.html" rel="external">
          "Lyme disease: Clinical manifestations in children"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7914.html" rel="external">
          "Diagnosis of Lyme disease"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7896.html" rel="external">
          "Treatment of Lyme disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3342719386">
         <span class="h1">
          CHARACTERISTICS OF SPIROCHETES THAT CAUSE LYME DISEASE
         </span>
        </p>
        <p class="headingAnchor" id="H342592157">
         <span class="h2">
          Classification and genome
         </span>
         <span class="headingEndMark">
          —
         </span>
         The spirochetes that cause Lyme disease are motile, spiral bacteria that are only distantly related to gram-negative and gram-positive pathogens. Spirochetes have two cellular membranes like gram-negative bacteria, but their flagella, the organelles of motility, are uniquely located between the inner and outer membrane, rather than on the surface.
         <em>
          B. burgdorferi
         </em>
         is 8 to 30 microns in length and about 0.2 microns in width. Their narrowness accounts for the inability to see unstained spirochetes by standard bright field light microscopy. (See
         <a class="local">
          'Culture and staining'
         </a>
         below.)
        </p>
        <p>
         The genomes of
         <em>
          B. burgdorferi
         </em>
         and the other five species of Lyme disease agents comprise small linear chromosomes of approximately 1000 kb, and up to 21 linear and circular plasmids totaling another 400 to 500 kb [
         <a href="#rid6">
          6-8
         </a>
         ]. The genes of the chromosomes are more similar between species and strains than those of the more divergent plasmids. Plasmids that carry genes for infectiousness are lost during serial cultivation in the laboratory [
         <a href="#rid9">
          9
         </a>
         ], thus, the preference for low-passage isolates in experiments.
        </p>
        <p>
         The spirochetes that cause Lyme disease were originally classified as members of the genus
         <em>
          Borrelia
         </em>
         [
         <a href="#rid10">
          10
         </a>
         ]. A new genus name,
         <em>
          Borreliella
         </em>
         ("borrelia-like"), distinguishes the spirochetes that cause Lyme disease from those that cause relapsing fever (which retain the genus
         <em>
          Borrelia
         </em>
         affiliation) within the family
         <em>
          Borreliaceae
         </em>
         [
         <a href="#rid5">
          5,11
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/7898.html" rel="external">
          "Microbiology, pathogenesis, and epidemiology of relapsing fever"
         </a>
         ).
         <em>
          Borreliella
         </em>
         also substitutes for the designation of "
         <em>
          Borrelia burgdorferi sensu lato
         </em>
         complex," which refers to a cluster of species that are closely related to
         <em>
          B. burgdorferi
         </em>
         .
         <em>
          B. burgdorferi
         </em>
         itself has commonly been distinguished in the literature from other "sensu lato" species by appending "sensu stricto," as in "
         <em>
          B. burgdorferi
         </em>
         sensu stricto."
        </p>
        <p>
         Although this new classification scheme has been formally accepted for the taxonomy of Lyme disease agents and closely related species, it is not in wide usage. Thus, the use of the medical term "borreliosis" for a disease (eg, as in Lyme borreliosis) and the name "borrelia" for an individual bacterium ("borrelias"or "borreliae" for plural) of
         <em>
          Borreliaceae
         </em>
         still apply.
        </p>
        <p class="headingAnchor" id="H342592788">
         <span class="h2">
          Antigens of B. burgdorferi and other Lyme disease species
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some antigens that are encoded by genes on the chromosome are important for diagnostic tests (eg, Western blots). These include flagellin (the major structural protein of flagella, with an apparent size by electrophoresis of 41 kDa), certain heat shock proteins (eg, a 60 kDa protein), an inner membrane protein of 39 kDa, an integral outer membrane protein of 66 kDa, and less-characterized proteins with apparent sizes 58 kDa and 93 kDa. (See
         <a class="medical medical_review" href="/z/d/html/7914.html" rel="external">
          "Diagnosis of Lyme disease", section on 'Serologic tests'
         </a>
         .)
        </p>
        <p>
         In addition, a unique feature of
         <em>
          B. burgdorferi
         </em>
         and other Lyme disease species is the large number of lipoproteins, which are anchored in the outer membrane by covalently linked fatty acids at their N-terminal ends [
         <a href="#rid6">
          6
         </a>
         ]. Plasmid-encoded antigens include the outer surface lipoproteins OspA (31 kDa), OspB (34 kDa) [
         <a href="#rid12">
          12
         </a>
         ], OspC (23 kDa) [
         <a href="#rid13">
          13
         </a>
         ], the decorin-binding proteins DbpA and DbpB (18 kDa) [
         <a href="#rid14">
          14
         </a>
         ], and the antigenically variable VlsE protein (35 kDa) [
         <a href="#rid15">
          15
         </a>
         ]. A conserved peptide of the VlsE proteins is the basis for the "C6" serological assay [
         <a href="#rid16">
          16
         </a>
         ]. The spirochete up- or down-regulates expression of some of these proteins at different times in its life cycle, presumably to suit each environment [
         <a href="#rid17">
          17,18
         </a>
         ].
        </p>
        <p>
         Not all of the proteins are expressed in cultured organisms. For example, VlsE, a major immunogen, is poorly expressed in culture. Therefore, VlsE is produced as a recombinant protein in
         <em>
          Escherichia coli
         </em>
         or its "C6" peptide is synthesized for use in immunodiagnostic assays.
        </p>
        <p class="headingAnchor" id="H620492271">
         <span class="h2">
          Culture and staining
         </span>
         <span class="headingEndMark">
          —
         </span>
         Direct detection of the organism can be difficult and is of limited value for diagnosis [
         <a href="#rid19">
          19
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7914.html" rel="external">
          "Diagnosis of Lyme disease"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Culture – Few clinical or public health laboratories perform cultures for
         <em>
          B. burgdorferi
         </em>
         and related species.
         <em>
          B. burgdorferi
         </em>
         and the other species have limited biosynthetic capabilities and require a complex medium for growth under microaerophilic conditions in vitro. Spirochetes have been isolated from skin, blood, and cerebrospinal fluid, as well as from ticks and various animals, in Barbour-Stoenner-Kelly medium or related formulations that contain multiple nutrients as well as bovine serum albumin and rabbit serum. However, under the best of circumstances, growth is slow, with generation times of six hours or longer.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Staining – The spirochetes can be visualized with silver stains or by immunofluorescence in biopsies of affected skin, although the numbers of bacteria are low. Unlike
         <em>
          B. burgdorferi
         </em>
         ,
         <em>
          B. mayonii
         </em>
         appears to reach high enough numbers in the blood of humans to be detectable in Wright- or Giemsa-stained smears of blood taken during acute infection [
         <a href="#rid20">
          20
         </a>
         ]. (See
         <a class="local">
          'Diversity of Lyme Disease species'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p>
         The most commonly performed direct detection assay is polymerase chain reaction (PCR), but the paucity of organisms in tissues and the disappearance of the organism from the blood within two to four weeks of infection onset limit its utility. A more detailed discussion of PCR testing is found elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/7914.html" rel="external">
          "Diagnosis of Lyme disease", section on 'Polymerase chain reaction'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8868578">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Borrelias do not produce potent toxins, but cause infection by migrating through tissues, disseminating in the blood, adhering to host cells, and evading immune clearance. There are no data showing that
         <em>
          B. burgdorferi
         </em>
         has a prolonged or transient intracellular phase in vivo that is not treatable by antibiotics.
        </p>
        <p>
         Under adverse conditions, spherical forms of the spirochetes may be observed. The outer membranes of the spirochetes may become detached from underlying cellular structures, but these so-called "cyst"-like forms do not represent a different stage in the life cycle of the spirochetes. There is no proven clinical significance for these "cyst"-like forms.
        </p>
        <p class="headingAnchor" id="H8868658">
         <span class="h2">
          Ecologic niche
         </span>
         <span class="headingEndMark">
          —
         </span>
         Borrelias are obligate parasites of arthropods and vertebrates; there are no known free-living forms [
         <a href="#rid4">
          4
         </a>
         ]. The spirochetes cycle between two different environments: the tick (a poikilothermic invertebrate without an adaptive immune system) and usually a mammal or bird (homeothermic vertebrates with well-developed adaptive immune systems). The Lyme disease agents are transmitted to humans almost exclusively by ticks. They may rarely be acquired by a penetrating injury contaminated with blood or through the bite of infected rodent; however, they are not acquired through aerosols, respiratory droplets, mucosal secretions, urine, feces, food, drinking water, or fomites. In addition, they are not transmitted by bedbugs, fleas, flies, lice, or mosquitoes. Although
         <em>
          B. burgdorferi
         </em>
         might persist in the testes, as is the case with a relapsing fever agent [
         <a href="#rid21">
          21
         </a>
         ], transmission of
         <em>
          B. burgdorferi
         </em>
         in the semen from a male to another person or through other forms of sexual contact has not been documented. (See
         <a class="medical medical_review" href="/z/d/html/7901.html" rel="external">
          "Epidemiology of Lyme disease"
         </a>
         .)
        </p>
        <p>
         Borrelias are microaerophilic and grow optimally in carbon dioxide concentrations typical of the tissues of mammals and birds. These bacteria are killed by exposure to temperatures over 50°C for more than a few minutes, hypotonic or hypertonic environments, drying, common disinfectants (eg, bleach), and detergents. They do not form spores. (See
         <a class="medical medical_review" href="/z/d/html/7895.html" rel="external">
          "Prevention of Lyme disease"
         </a>
         .)
        </p>
        <p>
         The small genome of borrelias encode comparatively few proteins with biosynthetic activity [
         <a href="#rid6">
          6
         </a>
         ]. Thus, these organisms depend upon the animal host or a rich culture medium in the laboratory for most nutritional requirements. (See
         <a class="local">
          'Culture and staining'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H8868665">
         <span class="h2">
          Protein expression
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          B. burgdorferi
         </em>
         expresses different repertoires of proteins to suit each environment [
         <a href="#rid22">
          22-24
         </a>
         ]. To transit from the tick midgut (where the
         <em>
          B. burgdorferi
         </em>
         are located prior to initiation of feeding) to the tick salivary gland, the organism down-regulates outer surface protein (Osp) A and upregulates OspC. Down-regulation of OspA facilitates detachment from the tick midgut and transit to the salivary glands [
         <a href="#rid25">
          25,26
         </a>
         ]. Expression of OspC facilitates invasion of bacteria into skin and subsequent dissemination [
         <a href="#rid27">
          27-29
         </a>
         ]. Additional discussions of outer surface proteins are found elsewhere. (See
         <a class="local">
          'Antigens of B. burgdorferi and other Lyme disease species'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/14008.html" rel="external">
          "Immunopathogenesis of Lyme disease", section on 'Outer surface protein variations'
         </a>
         .)
        </p>
        <p>
         Although
         <em>
          Borrelia
         </em>
         species do not produce lipid A-containing endotoxin [
         <a href="#rid30">
          30
         </a>
         ], they do produce lipoproteins that are ligands for toll-like receptors (TLR), namely a heterodimer of TLR2 and TLR1 [
         <a href="#rid31">
          31
         </a>
         ]. Binding to these receptors can lead to release of pro-inflammatory cytokines locally and systemically. A mild to moderate Jarisch-Herxheimer reaction may appear in some patients with early Lyme disease soon after the start of antibiotic treatment and the consequent lytic release from the spirochetes of lipoproteins and other constituents, such as peptidoglycan and flagella, for which there are other types of TLR receptors [
         <a href="#rid32">
          32
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14008.html" rel="external">
          "Immunopathogenesis of Lyme disease", section on 'Toll-like receptors'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7896.html" rel="external">
          "Treatment of Lyme disease", section on 'Jarisch-Herxheimer reaction'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H439683241">
         <span class="h2">
          Immune response
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some lipoproteins, such as the strain-specific OspC protein, appear to be T-cell independent antigens in hosts. This would explain the antibody responses to OspC during early infection that are limited to IgM and short-lived [
         <a href="#rid33">
          33
         </a>
         ]. Because
         <em>
          B. burgdorferi
         </em>
         do not secrete toxins, proteases, or other destructive molecules, the majority of the symptoms seen with human Lyme disease are due to the combined effects of the host innate and adaptive immune responses and lytic release of inflammatory bacterial components that follow. This is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/14008.html" rel="external">
          "Immunopathogenesis of Lyme disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H439683379">
         <span class="h1">
          DIVERSITY OF LYME DISEASE SPECIES
         </span>
        </p>
        <p class="headingAnchor" id="H4232166669">
         <span class="h2">
          Overview
         </span>
         <span class="headingEndMark">
          —
         </span>
         Three species account for most cases of Lyme disease in the world:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          B. burgdorferi
         </em>
         causes Lyme disease in North America and less extensively in Europe.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          B. afzelii
         </em>
         and
         <em>
          B. garinii
         </em>
         are the predominant species causing Lyme disease in Europe and Asia.
        </p>
        <p>
        </p>
        <p>
         Different species of
         <em>
          Ixodes
         </em>
         ticks serve as vectors in different regions. This is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/7901.html" rel="external">
          "Epidemiology of Lyme disease", section on 'Regional distribution'
         </a>
         .)
        </p>
        <p>
         Although the clinical manifestations and epidemiology of relapsing fever differ from Lyme disease, there is sufficient sequence similarity among certain
         <em>
          Borrelia
         </em>
         and
         <em>
          Borreliella
         </em>
         antigens for there to be cross-reactivity in some immunoassays for Lyme disease in persons infected with a relapsing fever agent [
         <a href="#rid34">
          34
         </a>
         ]. This is also the case for
         <em>
          Borrelia
         </em>
         <em>
          miyamotoi
         </em>
         , which causes a relapsing fever-like illness and is transmitted by the same species of
         <em>
          Ixodes
         </em>
         ticks that transmits Lyme disease [
         <a href="#rid35">
          35,36
         </a>
         ]. These agents are discussed in greater detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/7898.html" rel="external">
          "Microbiology, pathogenesis, and epidemiology of relapsing fever"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7897.html" rel="external">
          "Clinical features, diagnosis, and management of relapsing fever"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/101368.html" rel="external">
          "Borrelia miyamotoi infection"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1554126762">
         <span class="h2">
          Geographic distribution
         </span>
        </p>
        <p class="headingAnchor" id="H439683393">
         <span class="h3">
          The Americas
         </span>
         <span class="headingEndMark">
          —
         </span>
         In Northeastern and North-Central United States and bordering regions of Canada,
         <em>
          B. burgdorferi
         </em>
         is the principal cause of Lyme disease in humans [
         <a href="#rid37">
          37
         </a>
         ]. The organism is transmitted by
         <em>
          I. scapularis
         </em>
         ticks.
        </p>
        <p>
         In northern California, and some other coastal and foothill regions of far-western North America, human cases of Lyme disease are associated with exposure to
         <em>
          Ixodes pacificus
         </em>
         ticks.
         <em>
          I. pacificus
         </em>
         are infected with
         <em>
          B. burgdorferi,
         </em>
         but at a 10-fold lower frequency than occurs in the northeastern United States [
         <a href="#rid38">
          38,39
         </a>
         ].
        </p>
        <p>
         The other species known to cause Lyme disease in North America is
         <em>
          B. mayonii
         </em>
         , which
         <em>
         </em>
         is transmitted by
         <em>
          I. scapularis
         </em>
         ticks in north-central United States [
         <a href="#rid40">
          40
         </a>
         ].
         <em>
          B. mayonii
         </em>
         has been distinguished from
         <em>
          B. burgdorferi
         </em>
         by its ability to achieve higher concentrations in the blood in some patients. (See
         <a class="local">
          'Culture and staining'
         </a>
         above.)
        </p>
        <p>
         Several other
         <em>
          Borreliella
         </em>
         species in North America have life cycles involving
         <em>
          Ixodes
         </em>
         ticks; these include
         <em>
          B. americana
         </em>
         ,
         <em>
          B. andersoni
         </em>
         ,
         <em>
          B. bissettii
         </em>
         ,
         <em>
          B. californiensis
         </em>
         ,
         <em>
          B. carolinensis
         </em>
         ,
         <em>
          B. kurtenbachii
         </em>
         ,
         <em>
          B. lanei
         </em>
         ,
         <em>
         </em>
         and
         <em>
          B. maritima
         </em>
         [
         <a href="#rid41">
          41
         </a>
         ]. However, to date, none of these species have been established as causes of human disease (ie, they have not been isolated in culture from patients). The usual vectors of most of these other types of spirochetes are
         <em>
          Ixodes
         </em>
         species of ticks that humans would seldom encounter or be bitten by.
        </p>
        <p>
         In South America,
         <em>
          B. chilensis
         </em>
         was isolated from
         <em>
          Ixodes
         </em>
         ticks of that continent [
         <a href="#rid42">
          42
         </a>
         ]. Another novel species of
         <em>
          Borreliella
         </em>
         was identified in an
         <em>
          Ixodes
         </em>
         tick of birds in Brazil [
         <a href="#rid43">
          43
         </a>
         ]. However, the risk of either of these organisms to humans has not been established.
        </p>
        <p class="headingAnchor" id="H439683400">
         <span class="h3">
          Europe and Asia
         </span>
         <span class="headingEndMark">
          —
         </span>
         In Europe and Asia, there are four species known to cause Lyme disease. (See
         <a class="medical medical_review" href="/z/d/html/7901.html" rel="external">
          "Epidemiology of Lyme disease", section on 'Regional distribution'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In Europe,
         <em>
          B. afzelii
         </em>
         and
         <em>
          B. garinii
         </em>
         commonly infect humans [
         <a href="#rid44">
          44,45
         </a>
         ].
         <em>
          B. burgdorferi
         </em>
         is a less common cause in Europe and has not yet been found in Asia. Strains of
         <em>
          B. burgdorferi
         </em>
         in Europe and North America are unique to each continent [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In Asia,
         <em>
          B. afzelii
         </em>
         and
         <em>
          B. garinii
         </em>
         are also the most common causes of Lyme disease. Unlike North America and western Europe, where most infections are acquired from the bite of a nymphal tick, in Asia and Asian Russia, transmission to humans is mainly by the adult stage of the tick [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          B. bavariensis
         </em>
         is closely related to
         <em>
          B. garinii
         </em>
         [
         <a href="#rid48">
          48
         </a>
         ]. While
         <em>
          B. bavariensis
         </em>
         is distributed across the Eurasian continent, the infrequent cases of human disease have only been reported from Europe.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          B. spielmanii
         </em>
         has been infrequently isolated from patients with erythema migrans in Europe. In a survey from Germany, this species occurred less frequently in ticks than
         <em>
          B. garinii
         </em>
         ,
         <em>
          B. afzelii
         </em>
         , or
         <em>
          B. burgdorferi
         </em>
         [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         There are differences in the ecology of the species, especially between the two most prevalent species,
         <em>
          B. afzelii
         </em>
         and
         <em>
          B. garinii
         </em>
         .
         <em>
          B. afzelii
         </em>
         is mainly associated with rodents as reservoirs, whereas
         <em>
          B. garinii
         </em>
         is mainly associated with birds [
         <a href="#rid50">
          50,51
         </a>
         ]. This pattern of reservoir hosts for these spirochetes is attributed wholly, or in part, to the relative susceptibility of specific host complement lysis [
         <a href="#rid52">
          52
         </a>
         ]. (See
         <a class="local">
          'Ecologic niche'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/14008.html" rel="external">
          "Immunopathogenesis of Lyme disease", section on 'Evasion of complement-mediated killing'
         </a>
         .)
        </p>
        <p>
         There are several other varieties of
         <em>
          Borreliella
         </em>
         (
         <em>
          B. burgdorferi sensu lato
         </em>
         complex) species that have been identified in Europe and/or Asia in either
         <em>
          Ixodes
         </em>
         species ticks or vertebrate hosts. An example is
         <em>
          B. valaisiana
         </em>
         , first identified in Switzerland and subsequently in other parts of Europe and in Asia, but this and other species have not been documented as causes of human infections [
         <a href="#rid41">
          41,53
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H439683075">
         <span class="h2">
          Relationship to clinical manifestations
         </span>
        </p>
        <p class="headingAnchor" id="H3548164543">
         <span class="h3">
          Differences among species
         </span>
         <span class="headingEndMark">
          —
         </span>
         Biologic differences have been observed among the three predominant species of Lyme disease agents. In an in vitro study that included representatives of the three species,
         <em>
          B. burgdorferi
         </em>
         stimulated macrophages to secrete higher levels of cytokines and chemokines than did
         <em>
          B. afzelii
         </em>
         or
         <em>
          B. garinii
         </em>
         [
         <a href="#rid54">
          54
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14008.html" rel="external">
          "Immunopathogenesis of Lyme disease"
         </a>
         .)
        </p>
        <p>
         These biologic differences are likely to account for some of the differences in clinical manifestations in patients in Europe compared with North America. As an example, although all three species have been recovered from various sites in patients (eg, skin, blood, and cerebrospinal fluid), infection with
         <em>
          B. afzelii
         </em>
         is associated with a lower risk of neurologic disease than infection with either
         <em>
          B. garinii
         </em>
         or
         <em>
          B. burgdorferi
         </em>
         [
         <a href="#rid55">
          55
         </a>
         ]. The different clinical manifestations seen with each of the three species is not attributable to the higher frequency of bacteremia observed in
         <em>
          B. burgdorferi
         </em>
         infections [
         <a href="#rid56">
          56
         </a>
         ]. More detailed discussions of the clinical differences between Lyme disease in Europe and the United States are presented elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/7913.html" rel="external">
          "Clinical manifestations of Lyme disease in adults", section on 'United States versus Europe'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1573083666">
         <span class="h3">
          Differences among strains
         </span>
         <span class="headingEndMark">
          —
         </span>
         In Lyme disease-endemic regions of North America, there are usually 10 to 15 genetically distinct strains of
         <em>
          B. burgdorferi
         </em>
         circulating among wildlife and ticks in a given area [
         <a href="#rid37">
          37,38
         </a>
         ]. Strain typing by DNA sequence (genotyping) has been by outer surface protein C
         <em>
         </em>
         gene, a set of conserved chromosomal genes, and the spacer sequence between the 16S and 23S ribosomal RNA genes. The last typing scheme has been abbreviated "RST," and there are three major RST types: 1, 2, and 3 [
         <a href="#rid57">
          57
         </a>
         ]. However, these methods are being supplanted by whole-genome sequencing.
        </p>
        <p>
         The different strains can impact:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Immunity from infection
         </strong>
         – Immunity from infection is usually strain specific, and infection with one strain generally does not confer protection against another strain [
         <a href="#rid58">
          58
         </a>
         ]. However, more broadly protective immunity may develop across strains, especially after long-standing infections [
         <a href="#rid59">
          59
         </a>
         ]. As an example, reinfection has not been observed in patients with Lyme arthritis who typically have expanded antibody responses to many spirochetal proteins that persist for years [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk of dissemination
         </strong>
         – Some strains of
         <em>
          B. burgdorferi
         </em>
         are associated with a higher frequency of disseminated infection in humans and other mammals compared with others [
         <a href="#rid61">
          61-67
         </a>
         ]. In particular, RST1 strains have been associated with more severe early disease [
         <a href="#rid68">
          68
         </a>
         ] and more frequent antibiotic-refractory Lyme arthritis [
         <a href="#rid68">
          68,69
         </a>
         ]. However, the basis for differences in pathogenicity is not known. Whether identification of the strain of an infection will lead to more effective management of the patient (eg, a longer course of antibiotics for some strains) has not been evaluated.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inflammatory potential
         </strong>
         – Strains of
         <em>
          B. burgdorferi
         </em>
         from the United States and Europe were found to differ in their inflammatory potential. In general, United States strains generally elicit higher levels of cytokines and chemokines associated with innate and Th1-adaptive immune responses than
         <em>
          B. burgdorferi
         </em>
         strains from Europe [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         There are some strains of
         <em>
          B. burgdorferi
         </em>
         in the United States that occur in all three regions where the microbe is endemic: the Northeast, North-Central, and Far West. One of these is strain B31, which was the first laboratory isolate of this pathogen, and one of the most common. Other strains have more limited distributions (eg, occurring in the Midwest but not in the Northeast or the Far West) [
         <a href="#rid71">
          71
         </a>
         ]. The coexistence in an area of both local strains and widely distributed strains characterizes populations of
         <em>
          B. afzelii
         </em>
         and
         <em>
          B. garinii
         </em>
         in Europe as well [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
         The mix of strains in a given area is probably determined in part by the adaptive immune responses, including strain-specific antibodies, of host animals in the population over time [
         <a href="#rid58">
          58
         </a>
         ]. There may also be strain differences in host associations, such as different patterns of susceptibility to complement of various vertebrate species [
         <a href="#rid51">
          51,52
         </a>
         ]. Susceptibility of
         <em>
          B. burgdorferi
         </em>
         to the nonimmune, bactericidal effects of the serum of lizards is one of the explanations for the lower prevalence of
         <em>
          B. burgdorferi
         </em>
         in
         <em>
          Ixodes
         </em>
         ticks in the far-western and southeastern United States. Although lizards are common hosts for
         <em>
          I. pacificus
         </em>
         and
         <em>
          I. scapularis
         </em>
         ticks in these respective regions [
         <a href="#rid72">
          72
         </a>
         ], when an infected tick feeds on a lizard, the blood meal has a sterilizing action on spirochetes present in the gut of the feeding tick. (See
         <a class="medical medical_review" href="/z/d/html/14008.html" rel="external">
          "Immunopathogenesis of Lyme disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H342592214">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lyme disease is the most common tick-borne disease in the United States, Canada, and Europe. It is a bacterial infection caused by six species in the spirochete family
         <em>
          Borreliaceae
         </em>
         . The taxonomy of these spirochetes is undergoing revision, and the genus name may be represented as either
         <em>
          Borrelia
         </em>
         or
         <em>
          Borreliella
         </em>
         . (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lyme disease spirochetes are motile, spiral bacteria that are only distantly related to gram-negative and gram-positive pathogens. Their genomes comprise small linear chromosomes and linear and circular plasmids. (See
         <a class="local">
          'Classification and genome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Direct detection of the organism can be difficult.
         <em>
          B. burgdorferi
         </em>
         and the other species have limited biosynthetic capabilities and require a complex medium and microaerophilic conditions for growth in vitro. Under the best of circumstances, growth is slow. The spirochetes can be visualized with silver stains or by immunofluorescence in biopsies of affected skin; however, the numbers of bacteria are low. (See
         <a class="local">
          'Culture and staining'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          B. burgdorferi
         </em>
         and related species do not produce toxins but cause infection by migrating through tissues, adhering to host cells, and evading immune clearance. Illness also results from the inflammatory responses to the spirochete's presence. (See
         <a class="local">
          'Pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In
         <em>
         </em>
         North America, infection
         <em>
         </em>
         is caused primarily by
         <em>
          B. burgdorferi.
         </em>
         In Europe and Asia
         <em>
          , B. burgdorferi
         </em>
         is less common or absent, and infection is caused primarily by either
         <em>
          B afzelii
         </em>
         or
         <em>
          B. garinii
         </em>
         .
         <em>
         </em>
         (See
         <a class="local">
          'Geographic distribution'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Biologic differences have been observed between different species of Lyme disease agents and among strains within a given species. These are likely to account for some of the differences in clinical manifestations in patients in Europe and Asia compared with North America. (See
         <a class="local">
          'Relationship to clinical manifestations'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Steere AC, Strle F, Wormser GP, et al. Lyme borreliosis. Nat Rev Dis Primers 2016; 2:16090.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kullberg BJ, Vrijmoeth HD, van de Schoor F, Hovius JW. Lyme borreliosis: diagnosis and management. BMJ 2020; 369:m1041.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clin Infect Dis 2021; 72:1.
          </a>
         </li>
         <li class="breakAll">
          Barbour AG. Borelliaceae. In: Bergey's Manual of Systematics of Archaea and Bacteria, Trujillo ME, Dedysh P, DeVos P, et al (Eds), Wiley, Hoboken 2018.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barbour AG, Gupta RS. The Family Borreliaceae (Spirochaetales), a Diverse Group in Two Genera of Tick-Borne Spirochetes of Mammals, Birds, and Reptiles. J Med Entomol 2021; 58:1513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fraser CM, Casjens S, Huang WM, et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997; 390:580.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferdows MS, Barbour AG. Megabase-sized linear DNA in the bacterium Borrelia burgdorferi, the Lyme disease agent. Proc Natl Acad Sci U S A 1989; 86:5969.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casjens S, Palmer N, van Vugt R, et al. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 2000; 35:490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Norris SJ, Howell JK, Odeh EA, et al. High-throughput plasmid content analysis of Borrelia burgdorferi B31 by using Luminex multiplex technology. Appl Environ Microbiol 2011; 77:1483.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnson RC, Hyde FW, Rumpel CM. Taxonomy of the Lyme disease spirochetes. Yale J Biol Med 1984; 57:529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adeolu M, Gupta RS. A phylogenomic and molecular marker based proposal for the division of the genus Borrelia into two genera: the emended genus Borrelia containing only the members of the relapsing fever Borrelia, and the genus Borreliella gen. nov. containing the members of the Lyme disease Borrelia (Borrelia burgdorferi sensu lato complex). Antonie Van Leeuwenhoek 2014; 105:1049.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bergström S, Bundoc VG, Barbour AG. Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi. Mol Microbiol 1989; 3:479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Padula SJ, Dias F, Sampieri A, et al. Use of recombinant OspC from Borrelia burgdorferi for serodiagnosis of early Lyme disease. J Clin Microbiol 1994; 32:1733.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guo BP, Norris SJ, Rosenberg LC, Höök M. Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect Immun 1995; 63:3467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang JR, Hardham JM, Barbour AG, Norris SJ. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 1997; 89:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Branda JA, Linskey K, Kim YA, et al. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay. Clin Infect Dis 2011; 53:541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwan TG, Piesman J, Golde WT, et al. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci U S A 1995; 92:2909.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Battisti JM, Bono JL, Rosa PA, et al. Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector. Infect Immun 2008; 76:5228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clin Infect Dis 2021; 72:e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pritt BS, Mead PS, Johnson DK, et al. Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study. Lancet Infect Dis 2016; 16:556.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shamaei-Tousi A, Collin O, Bergh A, Bergström S. Testicular damage by microcirculatory disruption and colonization of an immune-privileged site during Borrelia crocidurae infection. J Exp Med 2001; 193:995.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Margolis N, Rosa PA. Regulation of expression of major outer surface proteins in Borrelia burgdorferi. Infect Immun 1993; 61:2207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Silva AM, Fikrig E. Arthropod- and host-specific gene expression by Borrelia burgdorferi. J Clin Invest 1997; 99:377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stevenson B. The Lyme disease spirochete, Borrelia burgdorferi, as a model vector-borne pathogen: insights on regulation of gene and protein expression. Curr Opin Microbiol 2023; 74:102332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pal U, Li X, Wang T, et al. TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi. Cell 2004; 119:457.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pal U, Yang X, Chen M, et al. OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J Clin Invest 2004; 113:220.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tilly K, Bestor A, Dulebohn DP, Rosa PA. OspC-independent infection and dissemination by host-adapted Borrelia burgdorferi. Infect Immun 2009; 77:2672.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tilly K, Krum JG, Bestor A, et al. Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection. Infect Immun 2006; 74:3554.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grimm D, Tilly K, Byram R, et al. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc Natl Acad Sci U S A 2004; 101:3142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takayama K, Rothenberg RJ, Barbour AG. Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun 1987; 55:2311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hirschfeld M, Kirschning CJ, Schwandner R, et al. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol 1999; 163:2382.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jutras BL, Lochhead RB, Kloos ZA, et al. Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis. Proc Natl Acad Sci U S A 2019; 116:13498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fung BP, McHugh GL, Leong JM, Steere AC. Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection. Infect Immun 1994; 62:3213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gettings JR, Lopez JE, Krishnavahjala A, et al. Antibodies to Borrelia turicatae in Experimentally Infected Dogs Cross-React with Borrelia burgdorferi Serologic Assays. J Clin Microbiol 2019; 57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barbour AG, Bunikis J, Travinsky B, et al. Niche partitioning of Borrelia burgdorferi and Borrelia miyamotoi in the same tick vector and mammalian reservoir species. Am J Trop Med Hyg 2009; 81:1120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Molloy PJ, Weeks KE, Todd B, Wormser GP. Seroreactivity to the C6 Peptide in Borrelia miyamotoi Infections Occurring in the Northeastern United States. Clin Infect Dis 2018; 66:1407.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoen AG, Margos G, Bent SJ, et al. Phylogeography of Borrelia burgdorferi in the eastern United States reflects multiple independent Lyme disease emergence events. Proc Natl Acad Sci U S A 2009; 106:15013.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Girard YA, Travinsky B, Schotthoefer A, et al. Population structure of the lyme borreliosis spirochete Borrelia burgdorferi in the western black-legged tick (Ixodes pacificus) in Northern California. Appl Environ Microbiol 2009; 75:7243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brummitt SI, Kjemtrup AM, Harvey DJ, et al. Borrelia burgdorferi and Borrelia miyamotoi seroprevalence in California blood donors. PLoS One 2020; 15:e0243950.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pritt BS, Respicio-Kingry LB, Sloan LM, et al. Borrelia mayonii sp. nov., a member of the Borrelia burgdorferi sensu lato complex, detected in patients and ticks in the upper midwestern United States. Int J Syst Evol Microbiol 2016; 66:4878.
          </a>
         </li>
         <li class="breakAll">
          Barbour AG, Qiu W. Boreliella. In: Bergey's Manual of Systematics of Archaea and Bacteria, Trujillo ME, Dedysh S, Devos P, et al (Eds), Wiley, Hoboken 2019.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ivanova LB, Tomova A, González-Acuña D, et al. Borrelia chilensis, a new member of the Borrelia burgdorferi sensu lato complex that extends the range of this genospecies in the Southern Hemisphere. Environ Microbiol 2014; 16:1069.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muñoz-Leal S, Ramirez DG, Luz HR, et al. "Candidatus Borrelia ibitipoquensis," a Borrelia valaisiana-Related Genospecies Characterized from Ixodes paranaensis in Brazil. Microb Ecol 2020; 80:682.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baranton G, Postic D, Saint Girons I, et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 1992; 42:378.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baranton G, De Martino SJ. Borrelia burgdorferi sensu lato diversity and its influence on pathogenicity in humans. Curr Probl Dermatol 2009; 37:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bunikis J, Garpmo U, Tsao J, et al. Sequence typing reveals extensive strain diversity of the Lyme borreliosis agents Borrelia burgdorferi in North America and Borrelia afzelii in Europe. Microbiology 2004; 150:1741.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Korenberg EI. Comparative ecology and epidemiology of lyme disease and tick-borne encephalitis in the former Soviet Union. Parasitol Today 1994; 10:157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Margos G, Wilske B, Sing A, et al. Borrelia bavariensis sp. nov. is widely distributed in Europe and Asia. Int J Syst Evol Microbiol 2013; 63:4284.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fingerle V, Schulte-Spechtel UC, Ruzic-Sabljic E, et al. Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int J Med Microbiol 2008; 298:279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stanek G, Reiter M. The expanding Lyme Borrelia complex--clinical significance of genomic species? Clin Microbiol Infect 2011; 17:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurtenbach K, De Michelis S, Etti S, et al. Host association of Borrelia burgdorferi sensu lato--the key role of host complement. Trends Microbiol 2002; 10:74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin YP, Diuk-Wasser MA, Stevenson B, Kraiczy P. Complement Evasion Contributes to Lyme Borreliae-Host Associations. Trends Parasitol 2020; 36:634.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Margos G, Sing A, Fingerle V. Published data do not support the notion that Borrelia valaisiana is human pathogenic. Infection 2017; 45:567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strle K, Drouin EE, Shen S, et al. Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii. J Infect Dis 2009; 200:1936.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest 2004; 113:1093.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maraspin V, Bogovič P, Ogrinc K, et al. Are Differences in Presentation of Early Lyme Borreliosis in Europe and North America a Consequence of a More Frequent Spirochetemia in American Patients? J Clin Med 2021; 10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barbour AG, Cook VJ. Genotyping Strains of Lyme Disease Agents Directly From Ticks, Blood, or Tissue. Methods Mol Biol 2018; 1690:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhatia B, Hillman C, Carracoi V, et al. Infection history of the blood-meal host dictates pathogenic potential of the Lyme disease spirochete within the feeding tick vector. PLoS Pathog 2018; 14:e1006959.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacquet M, Durand J, Rais O, Voordouw MJ. Cross-reactive acquired immunity influences transmission success of the Lyme disease pathogen, Borrelia afzelii. Infect Genet Evol 2015; 36:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kalish RA, McHugh G, Granquist J, et al. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis 2001; 33:780.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wormser GP, Brisson D, Liveris D, et al. Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J Infect Dis 2008; 198:1358.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones KL, Glickstein LJ, Damle N, et al. Borrelia burgdorferi genetic markers and disseminated disease in patients with early Lyme disease. J Clin Microbiol 2006; 44:4407.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seinost G, Dykhuizen DE, Dattwyler RJ, et al. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun 1999; 67:3518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liveris D, Varde S, Iyer R, et al. Genetic diversity of Borrelia burgdorferi in lyme disease patients as determined by culture versus direct PCR with clinical specimens. J Clin Microbiol 1999; 37:565.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang G, Ojaimi C, Wu H, et al. Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis 2002; 186:782.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hanincová K, Ogden NH, Diuk-Wasser M, et al. Fitness variation of Borrelia burgdorferi sensu stricto strains in mice. Appl Environ Microbiol 2008; 74:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tufts DM, Hart TM, Chen GF, et al. Outer surface protein polymorphisms linked to host-spirochete association in Lyme borreliae. Mol Microbiol 2019; 111:868.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strle K, Shin JJ, Glickstein LJ, Steere AC. Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis. Arthritis Rheum 2012; 64:1497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones KL, McHugh GA, Glickstein LJ, Steere AC. Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis. Arthritis Rheum 2009; 60:2174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cerar T, Strle F, Stupica D, et al. Differences in Genotype, Clinical Features, and Inflammatory Potential of Borrelia burgdorferi sensu stricto Strains from Europe and the United States. Emerg Infect Dis 2016; 22:818.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barbour AG, Travinsky B. Evolution and distribution of the ospC Gene, a transferable serotype determinant of Borrelia burgdorferi. MBio 2010; 1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lane RS, Quistad GB. Borreliacidal factor in the blood of the western fence lizard (Sceloporus occidentalis). J Parasitol 1998; 84:29.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 16138 Version 18.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27976670" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Lyme borreliosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32457042" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Lyme borreliosis: diagnosis and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33483734" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33483734" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33903910" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : The Family Borreliaceae (Spirochaetales), a Diverse Group in Two Genera of Tick-Borne Spirochetes of Mammals, Birds, and Reptiles.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9403685" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2762306" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Megabase-sized linear DNA in the bacterium Borrelia burgdorferi, the Lyme disease agent.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10672174" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21169439" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : High-throughput plasmid content analysis of Borrelia burgdorferi B31 by using Luminex multiplex technology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6393605" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Taxonomy of the Lyme disease spirochetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24744012" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : A phylogenomic and molecular marker based proposal for the division of the genus Borrelia into two genera: the emended genus Borrelia containing only the members of the relapsing fever Borrelia, and the genus Borreliella gen. nov. containing the members of the Lyme disease Borrelia (Borrelia burgdorferi sensu lato complex).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2761388" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7929767" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Use of recombinant OspC from Borrelia burgdorferi for serodiagnosis of early Lyme disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7642279" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Adherence of Borrelia burgdorferi to the proteoglycan decorin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9108482" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21865190" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7708747" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18779341" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33417672" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26856777" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11342584" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Testicular damage by microcirculatory disruption and colonization of an immune-privileged site during Borrelia crocidurae infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8478112" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Regulation of expression of major outer surface proteins in Borrelia burgdorferi.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9022068" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Arthropod- and host-specific gene expression by Borrelia burgdorferi.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37279610" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : The Lyme disease spirochete, Borrelia burgdorferi, as a model vector-borne pathogen: insights on regulation of gene and protein expression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15537536" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14722614" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19398538" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : OspC-independent infection and dissemination by host-adapted Borrelia burgdorferi.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16714588" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14970347" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3623705" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10452971" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31209025" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8039891" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31270181" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Antibodies to Borrelia turicatae in Experimentally Infected Dogs Cross-React with Borrelia burgdorferi Serologic Assays.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19996447" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Niche partitioning of Borrelia burgdorferi and Borrelia miyamotoi in the same tick vector and mammalian reservoir species.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29149281" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Seroreactivity to the C6 Peptide in Borrelia miyamotoi Infections Occurring in the Northeastern United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19706476" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Phylogeography of Borrelia burgdorferi in the eastern United States reflects multiple independent Lyme disease emergence events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19783741" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Population structure of the lyme borreliosis spirochete Borrelia burgdorferi in the western black-legged tick (Ixodes pacificus) in Northern California.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33370341" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Borrelia burgdorferi and Borrelia miyamotoi seroprevalence in California blood donors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27558626" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Borrelia mayonii sp. nov., a member of the Borrelia burgdorferi sensu lato complex, detected in patients and ticks in the upper midwestern United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27558626" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Borrelia mayonii sp. nov., a member of the Borrelia burgdorferi sensu lato complex, detected in patients and ticks in the upper midwestern United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24148079" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Borrelia chilensis, a new member of the Borrelia burgdorferi sensu lato complex that extends the range of this genospecies in the Southern Hemisphere.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32367214" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : "Candidatus Borrelia ibitipoquensis," a Borrelia valaisiana-Related Genospecies Characterized from Ixodes paranaensis in Brazil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1380285" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19367094" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Borrelia burgdorferi sensu lato diversity and its influence on pathogenicity in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15184561" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Sequence typing reveals extensive strain diversity of the Lyme borreliosis agents Borrelia burgdorferi in North America and Borrelia afzelii in Europe.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15275486" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Comparative ecology and epidemiology of lyme disease and tick-borne encephalitis in the former Soviet Union.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23838444" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Borrelia bavariensis sp. nov. is widely distributed in Europe and Asia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17616434" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21414082" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : The expanding Lyme Borrelia complex--clinical significance of genomic species?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11827808" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Host association of Borrelia burgdorferi sensu lato--the key role of host complement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32456964" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Complement Evasion Contributes to Lyme Borreliae-Host Associations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28573415" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Published data do not support the notion that Borrelia valaisiana is human pathogenic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19909078" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15085185" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The emergence of Lyme disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33916266" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Are Differences in Presentation of Early Lyme Borreliosis in Europe and North America a Consequence of a More Frequent Spirochetemia in American Patients?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29032532" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Genotyping Strains of Lyme Disease Agents Directly From Ticks, Blood, or Tissue.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29621350" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Infection history of the blood-meal host dictates pathogenic potential of the Lyme disease spirochete within the feeding tick vector.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26384476" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Cross-reactive acquired immunity influences transmission success of the Lyme disease pathogen, Borrelia afzelii.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11512082" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18781866" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17035489" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Borrelia burgdorferi genetic markers and disseminated disease in patients with early Lyme disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10377134" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9986813" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Genetic diversity of Borrelia burgdorferi in lyme disease patients as determined by culture versus direct PCR with clinical specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12198612" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17981941" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Fitness variation of Borrelia burgdorferi sensu stricto strains in mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30666741" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Outer surface protein polymorphisms linked to host-spirochete association in Lyme borreliae.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22246581" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19565522" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27088349" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Differences in Genotype, Clinical Features, and Inflammatory Potential of Borrelia burgdorferi sensu stricto Strains from Europe and the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20877579" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Evolution and distribution of the ospC Gene, a transferable serotype determinant of Borrelia burgdorferi.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9488334" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Borreliacidal factor in the blood of the western fence lizard (Sceloporus occidentalis).
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
